Biofrontera Inc. Common Stock
BFRIStockNASDAQ
$0.87 ▼ 2.39%
12 juin 2026
B
Biofrontera Inc. Common Stock
$0.87 ▼ 2.39%
12 juin 2026
BFRIStockNASDAQ

01 / À propos

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Arberion
Loading market data